Navigating the area of end-of-life care and access to medications like Nembutal in New South Wales, Australia, requires a careful comprehension of the intricate legal structure. Currently, this powerful sedative does not have a approved place on the Pharmaceutical Benefits Scheme (the scheme) and is therefore not commonly prescribed by medical prof